# Atlas Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/atlas-labs-2

- Industry: Healthcare IT
- Headquarters: Seattle, US
- Website: www.atlas.health
- Total disclosed funding: $42M
- Latest round: Series A (Nov 15, 2021)
- Investors on record: 5

## About

Founded in 2017 by CEO Ethan Davidoff, and based in Washington, US, Atlas Labs, Inc. operates as a  philanthropic medical financial aid company that helps hospitals and health systems to match, enroll, and collect patient assistance and health equity programs. In January 2022, Atlas Labs, Inc. raised USD 40 million in Series A funding led by new investor Felicis Ventures, with participation from other new investors GreatPoint Ventures and Tribe Capital. Returning investors Global Founders Capital and MBX Capital also participated in the round. The Series A funding values Atlas Labs at 141.5 million post-money.  

Atlas Labs offers an AI-Powered Patient Advocacy Solution for hospitals and health systems, this patient assistance solution combines an up-to-date database of more than 20,000 medical financial aid programs, AI-powered matching engine, enterprise workflow automation enrollment platform with pre-filled application data and integrated email, text messaging and eFax, and expert patient advocacy to submit claims and orders, track status, follow up, receive payments, drugs and log awards., and deliver reimbursement. 

The company will use the 2022 funding to meet demands and accelerate its go-to-market strategy.

## Funding rounds

- Series A, Nov 15, 2021, $42M — Felicis Ventures, GreatPoint Ventures, Global Founders Capital, Tribe Capital, MBX Capital

## Investors

- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series A
- GreatPoint Ventures (https://capitalatlas.ai/funds/greatpoint-ventures) — Series A
- Global Founders Capital (https://capitalatlas.ai/funds/global-founders-capital) — Series A
- Tribe Capital (https://capitalatlas.ai/funds/tribe-capital) — Series A
- MBX Capital (https://capitalatlas.ai/funds/mbx-capital) — Series A